Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Keren Yizhak et al.|Cell|2018Cited by 2k
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790MKenneth S. Thress, Geoffrey R. Oxnard, Cloud P. Paweletz et al.|Nature Medicine|2015Cited by 1.5k
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung CancerGeoffrey R. Oxnard, Pasi A. Jänne, Kenneth S. Thress et al.|Journal of Clinical Oncology|2016Cited by 843
Noninvasive Detection of Response and Resistance in <i>EGFR</i> -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNAGeoffrey R. Oxnard, Pasi A. Jänne, Cloud P. Paweletz et al.|Clinical Cancer Research|2014Cited by 781
Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to OsimertinibGeoffrey R. Oxnard, Pasi A. Jänne, Yuebi Hu et al.|JAMA Oncology|2018Cited by 689